- Home
- TLRY
TLRY
Tilray Brands Inc.
as 10-29-2025 4:00pm EST
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 1.7B | IPO Year: | 2018 |
| Target Price: | $1.50 | AVG Volume (30 days): | 96.0M |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.35 - $2.32 | Next Earning Date: | 10-09-2025 |
| Revenue: | $830,766,000 | Revenue Growth: | 2.31% |
| Revenue Growth (this year): | 7.28% | Revenue Growth (next year): | 4.56% |
Latest Tilray Brands Inc. News
TLRY Breaking Stock News: Dive into TLRY Ticker-Specific Updates for Smart Investing
Simply Wall St.
23 days ago
Exploring 3 Undervalued Small Caps With Insider Action In Global Markets
Yahoo Finance Video
25 days ago
Cannabis stocks are on a roll: Here's how to play the surge
Motley Fool
25 days ago
Should You Buy Tilray Brands Stock Before Oct. 9?
Associated Press Finance
a month ago
BC-Most Active Stocks
Motley Fool
a month ago
Why Tilray Brands Soared 40% This Week
Zacks
a month ago
Trump's CBD Video Sparks Buzz: 3 Cannabis Stocks to Watch
Motley Fool
a month ago
This Stock Has Doubled in the Past 6 Months: Is It Too Late to Buy?
Barchart
a month ago
This 1 Cannabis Dividend Stock Yields 3%
Compare TLRY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TLRY Tilray Brands Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.